Variables | Univariate analysis | ||
---|---|---|---|
OR | 95%CI | P | |
Recipient characteristics | |||
 Age, yr | 1.015 | (0.971–1.061) | 0.511 |
 Gender | 0.938 | (0.329–2.671) | 0.904 |
BMI, kg/m2 | 1.065 | (0.942–1.203) | 0.313 |
Time on dialysis, m | 1.008 | (0.995–1.021) | 0.239 |
Dialysis,HD | 1.295 | (0.534–3.143) | 0.568 |
Immunosuppression regimen | 1.056 | (0.314–3.544) | 0.930 |
Pre-Tx Creatinine, mg/dL | 1.000 | (0.988–1.002) | 0.987 |
history of hypertension | 0.258 | (0.065–1.027) | 0.055 |
history of diabetes mellitus | NA | NA | NA |
Donor characteristics | |||
 Age, yr | 1.004 | (0.976–1.032) | 0.787 |
 Gender | 3.500 | (0.713–17.176) | 0.123 |
BMI, kg/m2 | 1.022 | (0.890–1.173) | 0.760 |
Terminal Creatinine, mg/dL | 2.279 | (1.395–3.722) | 0.001 |
The donor type | Â | Â | 0.499 |
 DCD | REF | ||
 DBD | 1.714 | (0.228–12.890) | 0.601 |
 DBCD | 0.811 | (0.134–4.907) | 0.819 |
Donor history of hypertension | 3.419 | (1.206–9.695) | 0.021 |
Donor history of diabetes mellitus | 5.385 | (1.641–17.664) | 0.005 |
Transplant characteristics | |||
 CIT,h | 1.438 | (1.143–1.809) | 0.002 |
 HLA mismatches | 1.000 | (0.692–1.444) | 0.998 |
Donor serum markers | |||
 IL-2(pg/mL) | 1.036 | (1.013–1.059) | 0.002 |
 IL-4(pg/mL) | 0.857 | (0.663–1.107) | 0.238 |
 IL-6(pg/mL) | 0.800 | (0.595–1.076) | 0.140 |
 IL-10(pg/mL) | 1.007 | (0.990–1.025) | 0.407 |
 CTLA-4(pg/mL) | 1.000 | (0.992–1.008) | 0.908 |
 IL-35(pg/mL) | 1.002 | (0.834–1.205) | 0.982 |
HMGB1(pg/mL) | 1.000 | (1.000–1.000) | 0.481 |
Recipient serum markers | |||
 IL-2(pg/mL) | 0.990 | (0.968–1.013) | 0.990 |
 IL-4(pg/mL) | 1.128 | (0.826–1.539) | 0.449 |
 IL-6(pg/mL) | 0.881 | (0.623–1.247) | 0.476 |
 IL-10(pg/mL) | 0.993 | (0.969–1.017) | 0.553 |
 CTLA-4(pg/mL) | 1.000 | (0.990–1.009) | 0.960 |
 IL-35(pg/mL) | 1.008 | (0.815–1.245) | 0.943 |
Treg frequency(%) | 1.042 | (0.848–1.281) | 0.695 |